{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T17:56:35Z","timestamp":1781546195376,"version":"3.54.5"},"reference-count":7,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T00:00:00Z","timestamp":1762992000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Drugs Ther"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10557-025-07811-0","type":"journal-article","created":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T08:13:30Z","timestamp":1763021610000},"page":"835-836","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Comment On: \u201cDifferential Outcomes of Beta-Blockers According to Heart Rate Following Myocardial Infarction with Reduced Left Ventricular Ejection Fraction\u201d"],"prefix":"10.1007","volume":"40","author":[{"given":"Yimamujiang","family":"Aximu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peipei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,11,13]]},"reference":[{"key":"7811_CR1","doi-asserted-by":"publisher","unstructured":"Oh S, Kim JH, Cho KH, et al. Differential outcomes of Beta-Blockers according to heart rate following myocardial infarction with reduced left ventricular ejection fraction. Cardiovasc Drugs Ther Published Online Oct. 2025;16. https:\/\/doi.org\/10.1007\/s10557-025-07791-1.","DOI":"10.1007\/s10557-025-07791-1"},{"issue":"6","key":"7811_CR2","doi-asserted-by":"publisher","first-page":"e039678","DOI":"10.1161\/JAHA.124.039678","volume":"14","author":"KJ Lee","year":"2025","unstructured":"Lee KJ, Kim SE, Guk HS, et al. Persistent Beta-Blocker therapy reduces Long-Term mortality in patients with acute ischemic stroke with elevated heart rates. J Am Heart Assoc. 2025;14(6):e039678. https:\/\/doi.org\/10.1161\/JAHA.124.039678.","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"7811_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10557-024-07610-z","volume":"39","author":"MR Syed","year":"2025","unstructured":"Syed MR, Khan KS, Iman K. Beta-blockers and myocardial infarction: to \u03b2 -block or not to \u03b2 -block. Cardiovasc Drugs Ther. 2025;39(1):1\u20132. https:\/\/doi.org\/10.1007\/s10557-024-07610-z.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"5","key":"7811_CR4","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1007\/s10557-024-07626-5","volume":"38","author":"A Latif","year":"2024","unstructured":"Latif A, Jia X. Use of early intravenous beta blockers in patients with acute ST-segment elevation myocardial infarction without heart failure-revival or requiem? Cardiovasc Drugs Ther. 2024;38(5):973\u20135. https:\/\/doi.org\/10.1007\/s10557-024-07626-5.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"7811_CR5","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-024-67970-2","volume":"14","author":"H Saito","year":"2024","unstructured":"Saito H, Tanaka K, Ejiri H, et al. Elevated resting heart rate is associated with mortality in patients with chronic kidney disease. Sci Rep. 2024;14(1):17372. https:\/\/doi.org\/10.1038\/s41598-024-67970-2.","journal-title":"Sci Rep"},{"issue":"4","key":"7811_CR6","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1002\/ehf2.12153","volume":"4","author":"A Cohen-Solal","year":"2017","unstructured":"Cohen-Solal A, Jacobson AF, Pi\u00f1a IL. Beta blocker dose and markers of sympathetic activation in heart failure patients: interrelationships and prognostic significance. ESC Heart Fail. 2017;4(4):499\u2013506. https:\/\/doi.org\/10.1002\/ehf2.12153.","journal-title":"ESC Heart Fail"},{"key":"7811_CR7","doi-asserted-by":"publisher","unstructured":"Wang XT, Qin P. Comment on: effect of Bisoprolol versus other Beta-Blockers on glycemic control and metabolic parameters in type 2 diabetes: A retrospective cohort study. Cardiovasc Drugs Ther Published Online September. 2025;24. https:\/\/doi.org\/10.1007\/s10557-025-07782-2.","DOI":"10.1007\/s10557-025-07782-2"}],"container-title":["Cardiovascular Drugs and Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07811-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10557-025-07811-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10557-025-07811-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T05:21:13Z","timestamp":1778649673000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10557-025-07811-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,13]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7811"],"URL":"https:\/\/doi.org\/10.1007\/s10557-025-07811-0","relation":{},"ISSN":["0920-3206","1573-7241"],"issn-type":[{"value":"0920-3206","type":"print"},{"value":"1573-7241","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,13]]},"assertion":[{"value":"20 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}